Recent Insider Trading Activity
Real-time feed of open-market stock purchases and sales by corporate executives, directors, and 10% beneficial owners verified against official SEC Form 4 filings.
donut_large Market-Wide Insider Flow & Volume Breakdown
Real-time aggregate capital distribution across parsed SEC Form 4 filingsLive SEC Form 4 Transactions Stream
| Recency | Stock | Insider | Role | Type | Shares | Price | Total Value | SEC Form 4 | Actions |
|---|---|---|---|---|---|---|---|---|---|
| Today 2026-11-05 |
CRBG
🐋 Whale
Corebridge Financial, Inc.
|
NIPPON LIFE INSURANCE CO | 10% Owner | arrow_upward BUY | +348,195 | $36.15 | $12.59M | open_in_new Form 4 | |
| Today 2026-11-05 |
PAM
🐋 Whale
Pampa Energy Inc.
|
Mindlin Damian Miguel | President | arrow_upward BUY | +19,239 | $66.93 | $1.29M | open_in_new Form 4 | |
| Today 2026-11-05 |
PAM
🐋 Whale
Pampa Energy Inc.
|
Mindlin Damian Miguel | President | arrow_upward BUY | +19,413 | $68.43 | $1.33M | open_in_new Form 4 | |
| Today 2026-11-05 |
Liberty Global Ltd.
|
Rodriguez Enrique | Officer | arrow_upward BUY | +211,313 | $9.45 | $2.00M | open_in_new Form 4 | |
| Today 2026-11-05 |
Liberty Global Ltd.
|
FRIES MICHAEL T | CEO | arrow_upward BUY | +110,000 | $9.37 | $1.03M | open_in_new Form 4 | |
| Yesterday 2026-11-04 |
Aspen Neuroscience, Inc.
|
ORBIMED ADVISORS LLC | Director | arrow_upward BUY | +1,000,000 | $15.00 | $15.00M | open_in_new Form 4 | |
| Yesterday 2026-11-04 |
Aspen Neuroscience, Inc.
|
Thompson Peter A. | Director | arrow_upward BUY | +1,000,000 | $15.00 | $15.00M | open_in_new Form 4 | |
| Yesterday 2026-11-04 |
CRBG
🐋 Whale
Corebridge Financial, Inc.
|
NIPPON LIFE INSURANCE CO | 10% Owner | arrow_upward BUY | +190,251 | $35.23 | $6.70M | open_in_new Form 4 | |
| Yesterday 2026-11-04 |
DOLE
🐋 Whale
Dole plc
|
Pale Fire Capital SE | 10% Owner | arrow_upward BUY | +753,563 | $13.05 | $9.83M | open_in_new Form 4 | |
| Yesterday 2026-11-04 |
DOLE
🐋 Whale
Dole plc
|
Pale Fire Capital SE | 10% Owner | arrow_upward BUY | +230,294 | $13.26 | $3.05M | open_in_new Form 4 | |
| Yesterday 2026-11-04 |
KNOP
🐋 Whale
KNOT Offshore Partners LP
|
Seglem Trygve | Director | arrow_upward BUY | +2,083,333 | $20.88 | $43.50M | open_in_new Form 4 | |
| Yesterday 2026-11-04 |
CACC
🐋 Whale
CREDIT ACCEPTANCE CORP
|
TRYFOROS THOMAS N | Director | arrow_upward BUY | +3,000 | $485.20 | $1.46M | open_in_new Form 4 | |
| Yesterday 2026-11-04 |
INTC
🐋 Whale
Intel Corporation
|
TAN LIP BU | CEO | arrow_upward BUY | +150,000 | $64.73 | $9.71M | open_in_new Form 4 | |
| 2d ago 2026-11-03 |
SIRI
🐋 Whale
SIRIUS XM HOLDINGS INC.
|
BERKSHIRE HATHAWAY INC | 10% Owner | arrow_upward BUY | +113,348 | $30.23 | $3.43M | open_in_new Form 4 | |
| 2d ago 2026-11-03 |
SIRI
🐋 Whale
SIRIUS XM HOLDINGS INC.
|
BERKSHIRE HATHAWAY INC | 10% Owner | arrow_upward BUY | +66,968 | $29.47 | $1.97M | open_in_new Form 4 | |
| 2d ago 2026-11-03 |
SIRI
🐋 Whale
SIRIUS XM HOLDINGS INC.
|
BERKSHIRE HATHAWAY INC | 10% Owner | arrow_upward BUY | +743,965 | $28.89 | $21.49M | open_in_new Form 4 | |
| 2d ago 2026-11-03 |
LRN
🐋 Whale
Stride, Inc.
|
Haggart Dylan G. | Director | arrow_upward BUY | +31,357 | $75.04 | $2.35M | open_in_new Form 4 | |
| 2d ago 2026-11-03 |
LRN
🐋 Whale
Stride, Inc.
|
Haggart Dylan G. | Director | arrow_upward BUY | +75,000 | $77.01 | $5.78M | open_in_new Form 4 | |
| 2d ago 2026-11-03 |
LRN
🐋 Whale
Stride, Inc.
|
Haggart Dylan G. | Director | arrow_upward BUY | +50,000 | $77.23 | $3.86M | open_in_new Form 4 | |
| 2d ago 2026-11-03 |
LRN
🐋 Whale
Stride, Inc.
|
Haggart Dylan G. | Director | arrow_upward BUY | +50,000 | $78.33 | $3.92M | open_in_new Form 4 | |
| 2d ago 2026-11-03 |
Bambusa Therapeutics, Inc.
|
RA CAPITAL MANAGEMENT, L.P. | Director | arrow_upward BUY | +164,891 | $16.00 | $2.64M | open_in_new Form 4 | |
| 2d ago 2026-11-03 |
Bambusa Therapeutics, Inc.
|
RA CAPITAL MANAGEMENT, L.P. | Director | arrow_upward BUY | +2,335,109 | $16.00 | $37.36M | open_in_new Form 4 | |
| 2d ago 2026-11-03 |
Bambusa Therapeutics, Inc.
|
RA CAPITAL MANAGEMENT, L.P. | Director | arrow_upward BUY | +263,911 | $14.92 | $3.94M | open_in_new Form 4 | |
| 2d ago 2026-11-03 |
Bambusa Therapeutics, Inc.
|
RA CAPITAL MANAGEMENT, L.P. | Director | arrow_upward BUY | +189,909 | $14.23 | $2.70M | open_in_new Form 4 | |
| 2d ago 2026-11-03 |
PLBY
🐋 Whale
Playboy, Inc.
|
Docler Holding S.a r.l. | Director | arrow_upward BUY | +4,761,905 | $1.05 | $5.00M | open_in_new Form 4 | |
| 2d ago 2026-11-03 |
CRBG
🐋 Whale
Corebridge Financial, Inc.
|
NIPPON LIFE INSURANCE CO | 10% Owner | arrow_upward BUY | +223,981 | $34.61 | $7.75M | open_in_new Form 4 | |
| 2d ago 2026-11-03 |
MGM
🐋 Whale
MGM Resorts International
|
Meister Keith A. | Director | arrow_upward BUY | +1,504,076 | $29.75 | $44.75M | open_in_new Form 4 | |
| 2d ago 2026-11-03 |
MGM
🐋 Whale
MGM Resorts International
|
Meister Keith A. | Director | arrow_upward BUY | +233,998 | $28.92 | $6.77M | open_in_new Form 4 | |
| 3d ago 2026-11-02 |
Aspen Neuroscience, Inc.
|
ARCH Venture Fund X, L.P. | 10% Owner | arrow_upward BUY | +1,200,000 | $15.00 | $18.00M | open_in_new Form 4 | |
| 3d ago 2026-11-02 |
Aspen Neuroscience, Inc.
|
ARCH Venture Fund X, L.P. | 10% Owner | arrow_upward BUY | +66,667 | $15.00 | $1.00M | open_in_new Form 4 | |
| 3d ago 2026-11-02 |
Aspen Neuroscience, Inc.
|
ARCH Venture Partners XIV, L.P. | 10% Owner | arrow_upward BUY | +1,200,000 | $15.00 | $18.00M | open_in_new Form 4 | |
| 3d ago 2026-11-02 |
ROLLINS INC
|
LOR INC | 10% Owner | arrow_upward BUY | +1,444,402 | $34.59 | $49.96M | open_in_new Form 4 | |
| 3d ago 2026-11-02 |
ROLLINS INC
|
R. Randall Rollins Voting Trust U/A dated August 25, 1994 | 10% Owner | arrow_upward BUY | +1,444,402 | $34.59 | $49.96M | open_in_new Form 4 | |
| 3d ago 2026-11-02 |
CRBG
🐋 Whale
Corebridge Financial, Inc.
|
NIPPON LIFE INSURANCE CO | 10% Owner | arrow_upward BUY | +246,521 | $35.50 | $8.75M | open_in_new Form 4 | |
| 3d ago 2026-11-02 |
Bambusa Therapeutics, Inc.
|
Jeggle Helmut Wolfgang | Director | arrow_upward BUY | +375,000 | $16.00 | $6.00M | open_in_new Form 4 | |
| 3d ago 2026-11-02 |
Bambusa Therapeutics, Inc.
|
Salvia Investment GmbH | 10% Owner | arrow_upward BUY | +375,000 | $16.00 | $6.00M | open_in_new Form 4 | |
| 6d ago 2026-10-30 |
RAPP
🐋 Whale
Rapport Therapeutics, Inc.
|
HEALY JAMES | Director | arrow_upward BUY | +952,380 | $21.00 | $20.00M | open_in_new Form 4 | |
| 6d ago 2026-10-30 |
CRBG
🐋 Whale
Corebridge Financial, Inc.
|
NIPPON LIFE INSURANCE CO | 10% Owner | arrow_upward BUY | +245,898 | $35.26 | $8.67M | open_in_new Form 4 | |
| 1w ago 2026-10-29 |
DINO
🐋 Whale
HF Sinclair Corp
|
MYERS FRANKLIN | CEO | arrow_upward BUY | +10,000 | $110.80 | $1.11M | open_in_new Form 4 | |
| 1w ago 2026-10-29 |
SCQC
🐋 Whale
SPACCircle Acquisition Corp.
|
Das Soumen | Director | arrow_upward BUY | +266,590 | $10.00 | $2.67M | open_in_new Form 4 |
SEC Form 4 Trading Guide & Transaction Code Matrix
Under Section 16(a) of the Securities Exchange Act of 1934, corporate insiders—executives, directors, and beneficial owners holding greater than 10% of any registered equity class—must report changes in stock ownership within two business days. Not all filings carry equal predictive value. Tickzen automatically categorizes transactions using the official SEC Table I code matrix:
| SEC Code | Transaction Type | Capital Outlay | Signal Direction | Predictive Significance & Institutional Rationale |
|---|---|---|---|---|
| Code P | Open-Market Purchase | Discretionary (Personal Cash) | ▲ High Bullish | The insider commits their own capital to buy shares at current market prices. Strongest positive conviction signal. |
| Code S | Open-Market Sale | Discretionary (Disposition) | ▼ Variable / Caution | Discretionary disposition of shares. Often executed for tax planning, estate diversification, or pre-set Rule 10b5-1 plans; heavy clustered selling warrants caution. |
| Code A | Grant or Award | Non-Discretionary (Equity Comp) | ● Neutral | Restricted Stock Units (RSUs) or performance shares granted by compensation committees. Reflects compensation, not independent buying. |
| Code M | Option Exercise | Contractual Conversion | ● Neutral / Plan | Conversion of stock options into shares, commonly paired with an immediate cashless open-market sale (Code S) to pay exercise fees and taxes. |
| Code F | Tax Withholding | Mandatory Administrative | ● Neutral | Automatic surrender of shares to the issuing company to pay statutory income tax liabilities upon equity vesting. |
| Code G | Bona Fide Gift | Non-Market Transfer | ● Neutral | Charitable contribution or private transfer of shares to family trusts, non-profit institutions, or estate planning vehicles. |
Cluster Buying Dynamics
When 3 or more distinct corporate insiders purchase company stock within a 10-day window, academic studies show a statistically significant abnormal return over the subsequent 3 to 12 months compared to solitary executive purchases.
C-Suite vs. 10% Beneficial Owners
Chief Executive Officers (CEO) and Chief Financial Officers (CFO) possess daily operational oversight of sales pipelines and cost structures. Their discretionary purchases carry a much higher predictive signal than passive 10% hedge fund allocations.